Used in research and development for targeted cancer therapies, particularly in studies involving tumor growth inhibition. It neutralizes hepatocyte growth factor (HGF), which plays a key role in cancer cell proliferation, motility, and invasion. By blocking HGF activity, this antibody helps investigate signaling pathways related to MET receptor activation. Commonly applied in preclinical models to assess therapeutic potential in cancers such as gastric, colorectal, and hepatocellular carcinomas. Also utilized as a reference standard in immunoassays and binding studies to evaluate the performance of other anti-HGF agents.